211 related articles for article (PubMed ID: 29587283)
1. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
[TBL] [Abstract][Full Text] [Related]
2. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia.
Waldum HL; Rehfeld JF
Scand J Gastroenterol; 2019 Sep; 54(9):1118-1123. PubMed ID: 31524029
[TBL] [Abstract][Full Text] [Related]
4. Importance of gastrin in the pathogenesis and treatment of gastric tumors.
Burkitt MD; Varro A; Pritchard DM
World J Gastroenterol; 2009 Jan; 15(1):1-16. PubMed ID: 19115463
[TBL] [Abstract][Full Text] [Related]
5. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
Chuang CH; Sheu BS; Yang HB; Kao AW; Cheng HC; Yao WJ
J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
[TBL] [Abstract][Full Text] [Related]
6. Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach.
Waldum HL; Hauso Ø; Sørdal ØF; Fossmark R
Dig Dis Sci; 2015 Jun; 60(6):1522-7. PubMed ID: 25480404
[TBL] [Abstract][Full Text] [Related]
7. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
[TBL] [Abstract][Full Text] [Related]
8. The gastric mucosa 25 years after proximal gastric vagotomy.
Sagatun L; Jianu CS; Fossmark R; Mårvik R; Nordrum IS; Waldum HL
Scand J Gastroenterol; 2014 Oct; 49(10):1173-80. PubMed ID: 25157752
[TBL] [Abstract][Full Text] [Related]
9. Effects of Proton Pump Inhibitor Therapy,
Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
11. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
[TBL] [Abstract][Full Text] [Related]
12. Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.
Tatsuguchi A; Hoshino S; Kawami N; Gudis K; Nomura T; Shimizu A; Iwakiri K
Pathol Res Pract; 2020 Oct; 216(10):153113. PubMed ID: 32853950
[TBL] [Abstract][Full Text] [Related]
13. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
14. Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children.
Kato S; Ozawa K; Koike T; Sekine H; Ohara S; Minoura T; Iinuma K
Helicobacter; 2004 Apr; 9(2):100-5. PubMed ID: 15068410
[TBL] [Abstract][Full Text] [Related]
15. Duodenal gastrinoma with multiple gastric neuroendocrine tumors secondary to chronic Helicobacter pylori gastritis.
Grin A; Kim YI; Mustard R; Streutker CJ; Riddell RH
Am J Surg Pathol; 2012 Jun; 36(6):935-40. PubMed ID: 22588069
[TBL] [Abstract][Full Text] [Related]
16. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
17. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
[TBL] [Abstract][Full Text] [Related]
18. Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor.
Kleveland O; Syversen U; Slørdahl K; Waldum HL
Digestion; 2001; 64(2):71-4. PubMed ID: 11684818
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori infection. A reversible cause of hypergastrinemia and hyperchlorhydria which may mimic Zollinger-Ellison syndrome.
Metz DC; Weber HC; Orbuch M; Strader DB; Lubensky IA; Jensen RT
Dig Dis Sci; 1995 Jan; 40(1):153-9. PubMed ID: 7821103
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and differential diagnosis of hypergastrinemia.
Arnold R
Wien Klin Wochenschr; 2007; 119(19-20):564-9. PubMed ID: 17985088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]